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Helicobacter pylori has been isolated from the human stomach with media containing only minimal selective
agents. However, current research on the transmission and sources of infection requires more selective media
due to the higher numbers of contaminants in environmental, oral, and fecal samples. The objective of this
study was to develop and evaluate detection techniques that are sufficiently selective to isolate H. pylori from
potential animal and food sources. Since H. pylori survives in the acidic environment of the stomach, low pH
with added urea was studied as a potential selective combination. H. pylori grew fairly well on H. pylori Special
Peptone plating medium supplemented with 10 mM urea at pH 4.5, but this pH did not sufficiently inhibit the
growth of contaminants. Various antibiotic combinations were then compared, and a combination consisting
of 10 mg of vancomycin per liter, 5 mg of amphotericin B per liter, 10 mg of cefsulodin per liter, 62,000 IU of
polymyxin B sulfate per liter, 40 mg of trimethoprim per liter, and 20 mg of sulfamethoxazole per liter proved
to be highly selective but still allowed robust colonies of H. pylori to grow. This medium was highly selective for
recovering H. pylori from cattle and beef samples, and it is possible that it could be used to enhance the recovery
of this bacterium from human and environmental samples, which may be contaminated with large numbers of
competing microorganisms.
In 1982 Warren and Marshall (17) isolated a new spiral-
shaped bacterium from the stomachs of humans with gastric
ulcers, which was named Campylobacter pyloridis. Further re-
search on this novel bacterium revealed significant morpholog-
ical, biochemical, and genetic differences from other Campy-
lobacter spp., and the microorganism was eventually renamed
Helicobacter pylori (7). Since then, it has been determined that
H. pylori is the most prevalent bacterial pathogen in the world
and infects approximately one-half of the world’s population
(10). Infection with H. pylori causes numerous medical condi-
tions, including gastritis, peptic ulcers, gastric carcinomas, and
mucosa associated lymphoid tissue tumors (2, 9, 12).
It has not been necessary for the media used to isolate H.
pylori from the stomach to be highly selective because relatively
few contaminants survive in the low-pH environment of the
stomach (13). However, current research on the transmission
and sources of infection requires more selective media. In
several studies workers have tried to determine the prevalence
of H. pylori in the oral cavities or feces of infected patients, but
these efforts have been hindered by the large number of con-
taminants and the fastidious nature of the bacterium (3, 5, 16).
Therefore, the need for a more selective medium has become
increasingly important.
The objective of this study was to develop and evaluate
detection techniques that are selective enough so that H. pylori
can be isolated from potential animal and food sources. Since
H. pylori has the unique ability to survive in the highly acidic
environment of the stomach, techniques that capitalize on this
distinctive feature were examined. Lee (11) proposed that the
spiral morphology and rapid motility of H. pylori allow the
bacterium to penetrate the viscous coating of the stomach and
attach to the gastric mucosa and thus escape the harsh acidic
environment in the lumen of the stomach.
Another distinguishing feature of H. pylori is its exception-
ally high urease activity, which purportedly helps the bacterium
raise the pH of the surrounding fluid to a level which it can
tolerate (6). In addition to the possible protective effects of
urease in the acidic gastric environment, Williams et al. (18)
found that H. pylori utilizes urea as a nitrogen source for amino
acid synthesis. We surmised that urea might be added to a
selective medium at a low pH to further enhance the survival
of the organism. We also examined the effectiveness of addi-
tional selective agents, such as antibiotics and inhibitory dyes
that are routinely used to isolate enteric pathogens.
MATERIALS AND METHODS
Source and maintenance of cultures. Isolates of H. pylori (strains ATCC
43504, ATCC 43629, and ATCC 43579, all of which originated from human
gastric samples) were obtained from the American Type Culture Collection,
Rockville, Md. These organisms were maintained on H. pylori Special Peptone
agar (HPSPA) plates and were streaked onto fresh plates every 3 or 4 days (14a).
The plates were incubated at 37°C in 5.5-liter boxes (AnaeroPack; Mitsubishi
Gas Chemical Co., New York, N.Y.) that were flushed with a microaerophilic gas
mixture (6% O2, 10% CO2, 84% N2), which was used throughout this study.
Standard plating medium. Comparative studies performed in our laboratory
confirmed that the rate of growth and the subsequent colony size of H. pylori
were significantly greater on HPSPA than on any of the other media routinely
used to culture the bacterium (14a). HPSPA was prepared by adding 10 g of
Special Peptone (Oxoid Ltd., Basingstoke, England) per liter, 15 g of granulated
agar (Difco Laboratories, Detroit, Mich.) per liter, 5 g of sodium chloride (EM
Science, Gibbstown, N.J.) per liter, 5 g of yeast extract (Difco) per liter, 5 g of
beef extract (Becton Dickinson and Co., Cockeysville, Md.) per liter, and 0.5 g of
pyruvic acid (sodium salt; Sigma Chemical Co., St. Louis, Mo.) per liter to water.
Growth on acidified agar. H. pylori Special Peptone broth (HPSPB), brain
heart infusion broth, and Mueller-Hinton broth were inoculated with H. pylori
ATCC 43504 in order to prepare inocula that were plated onto acidified HPSPA
(pH 7.0, 6.5, 6.0, 5.5, and 5.0). Acidified agar was prepared by adding HCl to the
autoclaved media and measuring the pH to 60.1 pH unit with a pH meter
(model 612; Markson Science, Inc., Phoenix, Ariz.). Broth media were inoculated
with cells that had been harvested from one HPSPA plate with a sterile cotton
swab, dispersed in 9 ml of 0.1% peptone water (Difco), and vortexed for 10 s. The
same volume of the peptone water inoculum was dispensed into each 250-ml
Erlenmeyer flask (five flasks per medium) containing 96 ml of room temperature
broth and 4 ml of iron-supplemented calf serum (Biologos, Inc., Napersville, Ill.).
Each flask was flushed with a microaerophilic gas mixture, sealed with a sterile
rubber stopper, and incubated at 37°C. After the broth media were incubated for
24 and 48 h, samples were collected, and 0.1-ml portions of appropriate decimal
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dilutions were surface plated onto HPSPA with different pH values; a total of 30
replicates were prepared for each plating medium. Following inoculation, all of
the plates were placed in 5.5-liter plastic boxes (AnaeroPack) that were flushed
with a microaerophilic gas mixture and incubated at 37°C for 4 days. After
incubation, colonies were counted and measured by using a ruler and the mag-
nifying lens of a Quebec colony counter (Leica, Buffalo, N.Y.). Typical H. pylori
colonies (clear, circular, entire, convex, 0.5 to 1.5 mm in diameter) were identi-
fied on the basis of a positive urease reaction on Christensen’s urea agar (4), a
positive catalase test with hydrogen peroxide (Fisher, Fair Lawn, N.J.), and
typical curved-rod morphology after primary staining with crystal violet (Difco).
Additional experiments were conducted in order to compare growth on HP-
SPA at lower pH values (pH 7.0, 5.5, 5.0, 4.5, 4.0, and 3.5). Cells were harvested
from plates with a sterile cotton swab and dispersed in 9 ml of 0.1% peptone
water. After the preparation was vortexed for 10 s, 0.1-ml portions of appropriate
decimal dilutions were surface plated onto various plating media at different pH
values. Following inoculation, all of the plates were incubated for 4 days as
described above, and growth of H. pylori was evaluated by counting and mea-
suring the colonies.
Growth on acidified agar containing urea. H. pylori was grown by using HP-
SPA and different combinations of pH and urea concentrations (pH 5.5 and no
urea, pH 5.5 and 0.1 mM urea, pH 4.5 and no urea, pH 4.5 and 0.1 mM urea, pH
4.5 and 1 mM urea, pH 4.5 and 5 mM urea, pH 4.5 and 10 mM urea, pH 3.5 and
no urea, pH 3.5 and 0.1 mM urea, pH 3.5 and 1 mM urea, pH 3.5 and 5 mM urea,
pH 3.5 and 10 mM urea), and the results were compared. HPSPA batches having
different pH values were prepared, and various amounts of urea (Sigma) were
filter sterilized and added after the agar had been autoclaved and cooled to 48°C.
Cells were grown in 250-ml Erlenmeyer flasks containing HPSPB (two flasks for
each strain of H. pylori [ATCC 43504 and ATCC 43579]) in order to obtain
inocula for the various plating media. After the broth preparations were incu-
bated for 24 h, samples were collected from the broth preparations, and 0.1-ml
portions of appropriate decimal dilutions were surface plated onto the various
media. The plates were incubated for 4 days, and colonies were counted and
measured as described above.
Growth in the presence of TTC. Fifteen flasks containing broth (five flasks
containing HPSPB, five flasks containing Mueller-Hinton broth, and five flasks
containing brain heart infusion broth) were inoculated as described above in
order to obtain inocula for plating on standard HPSPA and HPSPA supple-
mented with 40 mg of triphenyl tetrazolium chloride (TTC) (U.S. Biochemical
Corp., Cleveland, Ohio) per liter. After the broth preparations were incubated
for 24 and 48 h, samples were collected from the broth preparations, and 0.1-ml
portions of appropriate decimal dilutions were surface plated onto the various
media; a total of 30 replicates were prepared for each plating medium. The plates
were incubated for 4 days as described above, and growth of H. pylori was
evaluated by counting and measuring the colonies.
Efficiency and selectivity of low pH values with various urea concentrations
compared with antibiotics as selective agents. We compared the efficiency of pH
4.5 HPSPA containing added urea (10, 20, or 40 mM) with the efficiency of
HPSPA containing four antibiotics (10 mg of vancomycin per liter, 10 mg of
amphotericin B per liter, 10 mg of cefsulodin per liter, and 10 mg of tri-
methoprim per liter). Cells were grown in HPSPB (three flasks for each strain of
H. pylori [ATCC 43504 and ATCC 43629]) in order to obtain inocula for the
various plating media. After the broth preparations were incubated for 24 and
48 h, samples were collected from the broth preparations, and 0.1-ml portions of
appropriate decimal dilutions were surface plated onto the various plating me-
dia; a total of 12 replicates were prepared for each plating medium. The plates
were incubated for 4 days as described above, and growth of H. pylori was
evaluated by counting and measuring the colonies.
We evaluated the selectivity of the media described above by collecting 9-cm2
sections of mucosa from the rumen, the initial portion of the abomasum (oma-
soabomasal ostium), which corresponds to the cardia of the stomach of mono-
gastric organisms, and the pyloric antrum of the abomasum of three cattle. These
samples were ground for 30 s with 5 ml of 0.1% peptone water by using a mortar
and pestle to release any Helicobacter spp. from the gastric pits within the mu-
cosa, and 0.25-ml portions of the resulting fluid were then surface plated in du-
plicate onto standard HPSPA and selective HPSPA. After the noninoculated
samples were plated, positive control plates were prepared by collecting three H.
pylori colonies from an HPSPA plate with a sterile cotton swab and swirling the
swab for 30 s in the fluid remaining in the mortar after the sample of mucosa had
been ground with the pestle. All positive control samples were inoculated in the
same manner. Portions (0.25 ml) of the inoculated sample fluid were then surface
plated onto the various selective media. The plates were incubated as described
above and examined after 4 and 7 days of incubation. Plates containing various
selective agents were compared by evaluating the densities of contaminating col-
onies on the plates. Positive control plates were examined to determine whether
they contained typical H. pylori colonies, which were identified as described above.
Selectivity of low pH compared with selectivity of four antibiotics when plates
were inoculated with ground beef samples. Separate flasks containing HPSPB
were inoculated with H. pylori ATCC 43504 or ATCC 43629 as described above
and were incubated at 37°C for 48 h under microaerophilic conditions. Nine
grams of fresh ground beef obtained from a local retail outlet was placed into a
sterile stomacher bag and inoculated with 1 ml of broth containing ca. 6.4 log10
CFU of H. pylori per ml. Duplicate samples were inoculated for each strain of
H. pylori, and a negative control was also included. Ninety milliliters of 0.1%
peptone water (Difco) was added to the bag, and the sample was pummeled for
1 min with a model 400 stomacher (Tekmar Co., Cincinnati, Ohio). Then 0.1-ml
portions of appropriate decimal dilutions were surface plated onto selective
HPSPA plates. The plates were incubated for 4 days and then examined to
determine whether they contained typical H. pylori colonies, which were counted
with a Quebec colony counter (Leica) and identified as H. pylori colonies as
described above.
Growth on HPSPA containing other combinations of antibiotics. Separate
flasks containing HPSPB were inoculated with H. pylori ATCC 43504, ATCC
43629, or ATCC 43579 and incubated as described above. Samples were taken
from the broth preparations after 24 and 48 h, and 0.1-ml portions of appropriate
decimal dilutions were surface plated onto standard HPSPA and HPSPA sup-
plemented with antibiotics. Various combinations of antibiotics were tested in
nine separate trials. In all of the trials the plates were incubated for 4 days, and
growth was evaluated by counting H. pylori colonies.
Selectivity of HPSPA containing additional antibiotics when it was inoculated
with rumen and abomasum samples from cattle. HPSPA preparations contain-
ing various combinations of antibiotics were inoculated with samples obtained
from the abomasum and rumen of six cattle as described above. The media
contained a basic combination consisting of 10 mg of amphotericin B per liter,
10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter, 40 mg of
trimethoprim per liter, and 20 mg of sulfamethoxazole per liter to which either
cycloheximide (20 or 40 mg/liter), vancomycin (20 or 40 mg/liter), or novobiocin
(40 mg/liter) was added. After inoculation, the plates were incubated for 7 days
as described above, and plates containing various selective agents were compared
by evaluating the densities of the contaminating colonies on the plates. This
procedure was repeated in a second trial by plating samples from 11 cattle onto
media containing a basic combination consisting of 10 mg of cefsulodin per liter,
62,000 IU of polymyxin B per liter, 40 mg of trimethoprim per liter, and 20 mg
of sulfamethoxazole per liter, to which either cycloheximide (10 mg/liter), cyclo-
heximide (10 mg/liter) and amphotericin B (5 mg/liter), cycloheximide (10 mg/
liter) and vancomycin (10 mg/liter), or cycloheximide (10 mg/liter) and nalidixic
acid (10 mg/liter) were added.
Statistical analysis. For all experiments, plate counts were converted to log10
CFU per milliliter prior to statistical analysis by using the General Linear Models
procedure of SAS (14). Duncan’s multiple range test was used for mean sepa-
ration (P , 0.05) in order to determine if there was a day effect for trials
performed over several days and for samples collected from broth preparations
after 24 and 48 h. If there were no day effects, data were combined, and log
reductions (log10 CFU per milliliter on nonselective medium 2 log10 CFU per
milliliter on medium containing selective agents) were compared.
RESULTS AND DISCUSSION
Growth on acidified agar. Because H. pylori survives in the
acidic environment of the human stomach, our initial efforts
were directed toward using low pH as a selective method to
inhibit competing organisms. Statistical analysis revealed that
there was no day effect in the experiment, so data obtained
after incubation for 24 and 48 h were combined. H. pylori grew
well at pH values of $5.5, but the colony size decreased sig-
nificantly from 1.0 mm at pH 7.0 to 0.8 mm at pH 5.0. Addi-
tional experiments in which peptone water inocula rather than
broth preparations were used showed that growth began to
diminish at pH 5.5. The colony size decreased from 0.9 mm at
pH 7.0 to 0.3 mm at pH 5.0. No growth was observed at pH
values of #4.5.
Growth on acidified agar supplemented with urea. When
urea was added at various concentrations, H. pylori grew well at
pH 4.5 but not at pH 3.5 (Table 1). Compared to the experi-
ment described above in which acidified agar was used, addi-
tion of urea resulted in good growth at pH 4.5, and at urea
concentrations of 1, 5, and 10 mM the colonies were relatively
large (diameters, 0.7 to 0.9 mm). The fact that adding urea
allowed the bacterium to grow at lower pH values is consistent
with other research which showed that survival of H. pylori
improved at low pH values when urea was present (1, 8).
Growth in the presence of TTC. The mean amount of H.
pylori recovered on HPSPA containing TTC or on HPSPA not
containing TTC was 5.8 log10 CFU/ml, suggesting that TTC did
not affect recovery of H. pylori. However, the mean colony
diameter was significantly reduced (P , 0.0001) from 0.9 mm
on HPSPA alone to 0.7 mm on HPSPA supplemented with












TTC, indicating that growth was slightly inhibited. Although
TTC has been used as a selective agent for H. pylori in one
medium (15), we decided that TTC would not be used as a
selective agent in this experiment because of the decrease in
colony size.
Efficiency and selectivity of low pH plus various urea con-
centrations versus antibiotics as selective agents. Adding an-
tibiotics (10 mg of vancomycin per liter, 10 mg of amphotericin
B per liter, 10 mg of cefsulodin per liter, and 10 mg of tri-
methoprim per liter) did not affect colony size (diameter, 1.3
mm) and only slightly reduced the rate of recovery (0.4-log
reduction) compared to standard HPSPA that did not contain
selective agents. In contrast, decreasing the pH of the plating
medium to 4.5 dramatically decreased the mean colony diam-
eter from 1.3 mm at pH 7 to 0.6 mm at pH 4.5 in the presence
of 10 mM urea. Various levels of urea (10, 20, or 40 mM) were
compared to determine if one particular urea concentration
enhanced growth of the bacterium at a low pH. Previous trials
had shown that both 5 and 10 mM urea supported satisfactory
growth of H. pylori at pH 4.5, but it was not known whether
higher concentrations of urea would further enhance growth of
the bacterium at a low pH. This experiment revealed that at
pH 4.5, 10 mM urea was more beneficial than either 20 or 40
mM urea. Increasing the urea concentration to 20 or 40 mM
decreased both the level of recovery and the growth rate of H.
pylori. It is plausible that the very potent urease activity in the
presence of high urea concentrations increased the pH to a
value at which H. pylori does not grow well, a possibility which
is consistent with other data describing the death of H. pylori at
high urea concentrations (8). These data suggest that using
antibiotics for selection may be more efficient for isolating H.
pylori because the antibiotics tested inhibited bacterial growth
less than low pH inhibited bacterial growth.
Visual evaluation of selective media inoculated with cattle
samples revealed a large number of contaminants on all of the
plates at pH 4.5, and many of the plates were covered with
gram-negative spreaders. HPSPA supplemented with antibiot-
ics allowed isolation of large numbers of H. pylori from all
positive control samples and inhibited contaminating colonies
much more effectively than low-pH (pH 4.5) HPSPA.
The only medium on which isolation of H. pylori from inoc-
ulated ground beef was efficient was HPSPA supplemented
with antibiotics; on this medium 4.5 and 4.4 log10 CFU of H.
pylori ATCC 43504 and ATCC 43629 per g, respectively, were
recovered. The initial inoculation level was 5.4 log10 CFU/g, so
an approximate 1-log reduction occurred during the inocula-
tion and recovery process. On low-pH (pH 4.5) HPSPA con-
taining various concentrations of urea (10, 20, or 40 mM) there
were numerous contaminants growing on the plates, which
prevented efficient isolation of H. pylori.
Since HPSPA supplemented with antibiotics (10 mg of van-
comycin per liter, 10 mg of amphotericin B per liter, 10 mg of
cefsulodin per liter, and 10 mg of trimethoprim per liter) re-
covered H. pylori from pure broth cultures more efficiently and
minimized the growth of contaminating microorganisms more
effectively, we decided that adding a combination of antibiotics
is a more efficient selective method for isolating H. pylori from
contaminated samples. Low pH (pH 4.5) and adding urea as
the sole selective agents proved to be ineffective for isolating
H. pylori from either bovine gastrointestinal samples or ground
beef samples. While the antibiotic concentrations used in this
experiment reduced the number of contaminants much more
efficiently than low pH reduced the number of contaminants,
these antibiotic concentrations still permitted a large number
of contaminants to grow when samples from the bovine rumen
were plated. Therefore, we compared additional antibiotic com-
binations that might enhance the selectivity of the medium.
Growth on HPSPA supplemented with additional combina-
tions of antibiotics. Determining the combinations of antibi-
otics and the highest concentrations of these antibiotics that
allowed good growth of H. pylori proved to be quite difficult
because of interactions and synergy among multiple antibiotics
and because of the fastidious nature of this bacterium. Numer-
ous combinations of antibiotics and concentrations were com-
pared in separate trials to determine the highest concentration
of each antibiotic or antibiotic combination that still allowed
acceptable growth of H. pylori (Table 2).
Trial 1 revealed that there were not significant differences in
the rate of recovery or colony size among the antibiotic com-
binations used in this trial except for the combinations con-
taining rifampin. When rifampin was added at a concentration
of 2 mg/liter, the colony size was significantly reduced, and
when it was added at a concentration of 4 mg/liter, H. pylori did
not grow. Trial 2 revealed that there were not significant dif-
ferences in the rate of recovery or colony size among the an-
tibiotic combinations used except when cefsulodin was added
at a concentration of $20 mg/liter. Adding 20 and 40 mg of
cefsulodin per liter significantly reduced the rate of recovery by
1.6 and 1.8 log, respectively, and adding 40 mg of cefsulodin
per liter significantly decreased the colony size.
Trial 3 revealed that there were not significant differences in
the rate of recovery between HPSPA and any of the antibiotic
combinations used, but colony size decreased with all of the
antibiotic combinations. The most dramatic decreases in col-
ony size occurred after the addition of either 124,000 IU of
polymyxin B per liter or 120 mg of trimethoprim per liter and
80 mg of sulfamethoxazole per liter, which reduced the colony
diameter from 1.2 mm to 0.3 and 0.4 mm, respectively. All
other antibiotic combinations decreased the colony diameter
from 1.2 mm to 0.5 to 0.6 mm, indicating that the bacterium
was moderately inhibited. Initially, the reductions in colony
size were considered acceptable when they were coupled with
the fact that the antibiotic combinations did not reduce the
rate of recovery. However, subsequent experiments revealed
that a concentration of novobiocin as low as 2.5 mg/liter dra-
matically reduced the growth of H. pylori.
Trial 4 showed that no growth of H. pylori occurred when we
used antibiotic combinations containing 10 mg of novobiocin
TABLE 1. Mean reductions in plate counts and colony sizes when
H. pylori was plated from broth preparations onto media
with various pH values and urea concentrations
pH Urea concn(mM)




5.5 0 0.0 Ab 0.9 A
5.5 0.1 0.1 A 0.7 AB
4.5 0 0.8 A 0.1 C
4.5 0.1 0.1 A 0.2 BC
4.5 1 10.2 Ac 0.7 A
4.5 5 0.0 A 0.9 A
4.5 10 10.3 A 0.7 AB
3.5 10d .3.1 Be NG D f
a Reduction 5 mean log10 CFU per milliliter on HPSPA at pH 5.5 2 mean
log10 CFU per milliliter on HPSPA at a different pH and urea concentration.
b Values in the same column followed by the same letter are not significantly
different (P , 0.05).
c A plus sign indicates that the plate counts were higher than the HPSPA plate
counts at pH 5.5.
d Lower levels of urea (0, 0.1, 1, and 5 mM) were also tested, but no growth was
observed.
e Below the limit of detection.
f NG, no growth.












per liter. There were not significant differences in the rates of
recovery obtained with the other antibiotic combinations used
in this trial, and colony size was not significantly decreased by
10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per
liter, 40 mg of trimethoprim per liter, and 20 mg of sulfameth-
oxazole per liter. These data indicate that adding novobiocin to
the other four antibiotics inhibited growth of H. pylori.
In trial 5 there were not significant differences in the rate of
recovery between HPSPA without antibiotics and HPSPA con-
taining any of the antibiotic combinations. The colony diame-
TABLE 2. Mean reductions in plate counts and colony sizes when H. pylori was plated from broth preparations onto media
containing various combinations of antibioticsa
Trial Antibiotic(s) Reduction in plate counts(log10 CFU/ml)b
Colony diam
(mm)
1c None 0.0 Ad 1.3 A
VACT, nalidixic acid (10 mg/liter)e 0.0 A 1.2 A
VACT, polymyxin B (62,000 IU/liter) 0.0 A 1.2 A
VACT, cycloheximide (10 mg/liter) 0.0 A 1.3 A
VACT, rifampin (2 mg/liter) 2.5 B 0.1 B
VACT, rifampin (4 mg/liter) NGf NG
2 None 0.0 A 1.2 A
VAPT, cefsulodin (10 mg/liter)g 0.2 A 1.1 AB
VAPT, cefsulodin (20 mg/liter) 1.6 B 1.0 B
VAPT, cefsulodin (40 mg/liter) 1.8 B 0.8 C
VAPT, cefsulodin (10 mg/liter), sulfamethoxazole (8 mg/liter) 0.1 A 1.1 AB
VAPT, cefsulodin (10 mg/liter), sulfamethoxazole (16 mg/liter) 0.0 A 1.1 AB
3 None 0.0 A 1.2 A
VACPTS, novobiocin (10 mg/liter)h 0.4 A 0.7 B
VACPTS, novobiocin (20 mg/liter) 0.2 A 0.6 B
VACTS, polymyxin B (124,000 IU/liter)h 0.2 A 0.3 C
VACPS, trimethoprim (60 mg/liter)h 0.7 A 0.6 B
VACP, trimethoprim (120 mg/liter), sulfamethoxazole (80 mg/liter)h 0.4 A 0.4 C
4 None 0.0 A 0.9 A
Polymyxin B (62,000 IU/liter) 0.4 A 1.2 B
Cefsulodin (10 mg/liter), polymyxin B (62,000 IU/liter) 0.9 A 1.1 B
CPTSi 1.0 A 1.0 A
CPTS, novobiocin (10 mg/liter) NG NG
CPTS, novobiocin (10 mg/liter), amphotericin B (10 mg/liter) NG NG
5 None 0.0 A 0.9 A
VCPTSCj 0.1 A 0.8 B
VCPTSC, nalidixic acid (10 mg/liter) 0.1 A 0.7 B
VCPTSC, nalidixic acid (10 mg/liter), amphotericin B (2.3 mg/liter) 0.1 A 0.7 B
VCPTSC, nalidixic acid (10 mg/liter), amphotericin B (4.5 mg/liter) 0.2 A 0.7 B
Novobiocin (2.5 mg/liter) 0.2 A 0.5 C
6 None 0.0 A 0.8 A
CPTSCk 0.1 A 0.8 A
CPTSC, amphotericin B (2.5 mg/liter) 0.1 A 0.8 A
CPTSC, amphotericin B (5 mg/liter), vancomycin (10 mg/liter) 0.1 A 0.8 A
CPTSC, amphotericin B (5 mg/liter), vancomycin (10 mg/liter), nalidixic acid (10 mg/liter) 0.2 A 0.7 A
7 None 0.0 A 0.9 A
VACPTSl 0.4 A 0.7 B
a HPSPA (pH 7.0) was the standard plating medium, and various combinations of antibiotics were added to this medium.
b Reduction 5 mean log10 CFU per milliliter on HPSPA without antibiotics 2 mean log10 CFU per milliliter on HPSPA containing antibiotic(s).
c Statistical analysis revealed that there was a day effect, so data from each trial were evaluated separately.
d Values in the same column for the same trial followed by the same letter are not significantly different (P , 0.05).
e In trial 1, VACT consisted of 10 mg of vancomycin per liter, 10 mg of amphotericin B per liter, 10 mg of cefsulodin per liter, and 10 mg of trimethoprim per liter.
f NG, no growth.
g In trial 2, VAPT consisted of 10 mg of vancomycin per liter, 10 mg of amphotericin B per liter, 62,000 IU of polymyxin B per liter, and 20 mg of trimethoprim per liter.
h In trial 3, VACPTS consisted of 10 mg of vancomycin per liter, 10 mg of amphotericin B per liter, 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter,
20 mg of trimethoprim per liter, and 20 mg of sulfamethoxazole per liter; VACTS consisted of 10 mg of vancomycin per liter, 10 mg of amphotericin B per liter, 10
mg of cefsulodin per liter, 20 mg of trimethoprim per liter, and 20 mg of sulfamethoxazole per liter; VACPS consisted of 10 mg of vancomycin per liter, 10 mg of
amphotericin B per liter, 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter, and 20 mg of sulfamethoxazole per liter; and VACP consisted of 10 mg of
vancomycin per liter, 10 mg of amphotericin B per liter, 10 mg of cefsulodin per liter, and 62,000 IU of polymyxin B per liter.
i In trial 4, CPTS consisted of 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter, 20 mg of trimethoprim per liter, and 10 mg of sulfamethoxazole per liter.
j In trial 5, VCPTSC consisted of 10 mg of vancomycin per liter, 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter, 40 mg of trimethoprim per liter,
20 mg of sulfamethoxazole per liter, and 10 mg of cycloheximide per liter.
k In trial 6, CPTSC consisted of 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter, 20 mg of trimethoprim per liter, 10 mg of sulfamethoxazole per
liter, and 10 mg of cycloheximide per liter.
l In trial 7, VACPTS consisted of 10 mg of vancomycin per liter, 5 mg of amphotericin B per liter, 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B per liter,
40 mg of trimethoprim per liter, and 20 mg of sulfamethoxazole per liter.












ter was reduced by 0.1 to 0.2 mm by most of the antibiotic
combinations; the only exception was 2.5 mg of novobiocin per
liter, which decreased the colony diameter from 0.9 to 0.5 mm.
Although the reductions in colony size were statistically signif-
icant, all of the antibiotic combinations except 2.5 mg of no-
vobiocin per liter still allowed relatively large colonies (diam-
eter, 0.7 to 0.8 mm) to grow. Coupled with the fact that the
antibiotic combinations did not reduce the rate of recovery, the
minor reductions in colony size were considered acceptable.
These data provide further evidence that novobiocin, even at a
low level (2.5 mg/liter), inhibits the growth of H. pylori; this
conclusion is consistent with the results of trial 4 and 3 addi-
tional trials (data not shown), in which novobiocin at a con-
centration of $10 mg/liter prevented the growth of H. pylori.
We were reluctant to eliminate novobiocin as a selective agent
because it dramatically decreased the numbers of contami-
nants in bovine samples and because the trial 3 results indi-
cated that H. pylori was somewhat resistant to novobiocin.
However, on the basis of the data from four trials, we con-
cluded that H. pylori is sensitive to novobiocin even at low
concentrations, so novobiocin was eliminated from consider-
ation as a selective agent.
Trials 6 and 7 provided final confirmatory evidence that H.
pylori grows well in the presence of 10 mg of vancomycin per
liter, 5 mg of amphotericin B per liter, 10 mg of cefsulodin per
liter, 62,000 IU of polymyxin B per liter, 40 mg of trimethoprim
per liter, and 20 mg of sulfamethoxazole per liter.
Selectivity of HPSPA containing additional antibiotics when
it is inoculated with rumen and abomasum samples from
cattle. All of the antibiotic combinations used in trial 1 limited
the growth of contaminants, and individual colonies were eas-
ily identified. Media containing vancomycin (20 or 40 mg/liter)
instead of cycloheximide contained fewer contaminants and
allowed easier identification of individual colonies. These com-
binations of antibiotics also allowed successful isolation of nu-
merous colonies of H. pylori from most positive control sam-
ples. This trial revealed that antibiotic combinations containing
20 mg of vancomycin per liter, 10 mg of amphotericin B per
liter, 10 mg of cefsulodin per liter, 62,000 IU of polymyxin B
per liter, 20 mg of trimethoprim per liter, and 20 mg of sulfa-
methoxazole per liter efficiently prevent growth of contami-
nants but still allow outgrowth and isolation of H. pylori.
In trial 2 HPSPA containing 10 mg of cefsulodin per liter,
62,000 IU of polymyxin B per liter, 40 mg of trimethoprim per
liter, and 20 mg of sulfamethoxazole per liter permitted growth
of several contaminants, but individual colonies of H. pylori
were still easily identified and isolated. Adding 10 mg of nali-
dixic acid per liter or 10 mg of cycloheximide per liter to the
basic antibiotic combination did not improve the selectivity.
However, adding 5 mg of amphotericin B per liter to the basic
antibiotic combination enhanced the selectivity, and adding 10
mg of vancomycin per liter further enhanced the selectivity.
Thus, the combination consisting of 10 mg of vancomycin per
liter, 5 mg of amphotericin B per liter, 10 mg of cefsulodin per
liter, 62,000 IU of polymyxin B per liter, 40 mg of trimethoprim
per liter, and 20 mg of sulfamethoxazole per liter eliminated
growth of a large number of contaminants but still allowed
successful isolation of numerous colonies of H. pylori from
positive control samples, which confirmed the results obtained
in trial 1.
The medium described in this paper was designed and tested
for the ability to recover H. pylori from cattle samples. Because
of the fastidious nature of this organism, defining selective
agents that inhibit large numbers of contaminants while still
allowing H. pylori to grow well is extremely challenging, yet the
final selective HPSPA formulation, which includes 10 mg of
vancomycin per liter, 5 mg of amphotericin B per liter, 10 mg
of cefsulodin per liter, 62,000 IU of polymyxin B per liter, 40
mg of trimethoprim per liter, and 20 mg of sulfamethoxazole
per liter, has proven to be highly selective while still permitting
growth of large colonies of H. pylori. This medium, which is
effective for isolating H. pylori from inoculated cattle and beef
samples, may also be useful for recovering this pathogen from
both human and environmental samples that may be contam-
inated with large numbers of competing microorganisms.
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